Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | BMY | AMGN | GILD | VRTX |
| Company | Cytokinetics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 68.21 | 43.56 | 309.53 | 65.18 | 419.00 |
| High | 68.44 | 43.98 | 311.19 | 65.22 | 421.18 |
| Low | 61.75 | 43.50 | 306.32 | 64.66 | 416.03 |
| Last | 63.93 | 43.90 | 311.53 | 64.68 | 417.02 |
| Change | -1.34 | +0.23 | +4.22 | -0.24 | -1.80 |
| % Change | -2.05% | +0.53% | +1.37% | -0.37% | -0.43% |
| Volume | 796,287 | 2,472,156 | 668,562 | 1,302,960 | 163,724 |
| 20-Day Average Volume | 1,113,494 | 13,936,016 | 2,791,198 | 7,217,794 | 1,088,292 |
| Previous Close | 65.27 | 43.67 | 307.31 | 64.92 | 418.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 65.81 | 46.13 | 279.37 | 66.11 | 400.52 |
| 20-Day Raw Stochastic | 24.38% | 8.54% | 81.09% | 10.52% | 74.45% |
| 20-Day Relative Strength | 43.12% | 30.24% | 67.32% | 32.35% | 58.23% |
| Weighted Alpha | +4.76 | -36.45 | +34.47 | -21.28 | +20.55 |
| Today's Opinion | 8% Sell | 100% Sell | 56% Buy | 100% Sell | 56% Buy |
| Previous Opinion | 8% Sell | 100% Sell | 56% Buy | 100% Sell | 56% Buy |
| Last Month's Opinion | 88% Buy | 48% Sell | 40% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.52% since 05/02/24 | +0.38% since 05/02/24 | +11.67% since 05/02/24 | -0.84% since 05/02/24 | +4.16% since 05/02/24 |
| Low | 61.75 on 05/09/24 | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 394.03 on 05/07/24 |
| High | 68.44 on 05/09/24 | 44.62 on 05/06/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -14.72% since 04/09/24 | -14.99% since 04/09/24 | +14.99% since 04/09/24 | -7.38% since 04/09/24 | +3.05% since 04/09/24 |
| Low | 60.86 on 04/30/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 75.50 on 04/11/24 | 51.28 on 04/10/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | -16.81% since 02/09/24 | -11.94% since 02/09/24 | +6.79% since 02/09/24 | -12.07% since 02/09/24 | -1.44% since 02/09/24 |
| Low | 60.86 on 04/30/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 81.36 on 02/27/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | +93.31% since 11/09/23 | -12.98% since 11/09/23 | +17.73% since 11/09/23 | -13.60% since 11/09/23 | +13.09% since 11/09/23 |
| Low | 30.68 on 11/28/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 110.25 on 01/08/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,825,675 | 88,523,448 | 164,851,840 | 80,830,400 | 108,247,808 |
| Shares Outstanding, K | 104,576 | 2,027,100 | 536,435 | 1,245,077 | 258,459 |
| Annual Sales | 7,530,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -526,240,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 1,670,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -136,900,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 0.72 | 0.45 | 0.60 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.33 on 05/08/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/08/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.94 | 16.12 | 16.24 | 27.24 |